Title: Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial
Authors: Kappos, Ludwig ×
Freedman, Mark
Polman, Chris
Edan, Gilles
Hartung, Hans-Peter
Miller, David
Montalban, Xavier
Barkhof, Frederik
Radü, Ernst-Wilhelm
Metzig, Carola
Bauer, Lars
Lanius, Vivian
Sandbrink, Rupert
Pohl, Christoph
Dubois, Bénédicte
BENEFIT study group #
Issue Date: Nov-2009
Publisher: Lancet Pub. Group
Series Title: The Lancet Neurology vol:8 pages:987-997
ISSN: 1474-4422
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Research Group Experimental Neurology
Laboratory for Neuroimmunology
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
BENEFIT_long term.pdf Published 239KbAdobe PDFView/Open


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science